NCT06505941View on ClinicalTrials.gov

Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 20, 2024

Primary Completion Date

November 20, 2025

Study Completion Date

February 20, 2027

Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG

umbilical cord mesenchymal stem cell

umbilical cord mesenchymal stem cell

DRUG

Placebo

non-cell-containing placebo

All Listed Sponsors
collaborator

Zhongda Hospital

OTHER

collaborator

Yinguan Biologics, Shenzheng

UNKNOWN

lead

Southeast University, China

OTHER

NCT06505941 - Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS | Biotech Hunter | Biotech Hunter